栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 2,001 | 2,031 | 1,950 | 1,969 | -61 | -3% | 225,600 |
2019/05/17 | 2,023 | 2,056 | 2,017 | 2,030 | +47 | +2.4% | 218,500 |
2019/05/16 | 1,991 | 2,007 | 1,965 | 1,983 | -16 | -0.8% | 233,300 |
2019/05/15 | 2,050 | 2,050 | 1,994 | 1,999 | -35 | -1.7% | 185,400 |
2019/05/14 | 2,000 | 2,076 | 1,981 | 2,034 | -5 | -0.2% | 401,500 |
2019/05/13 | 2,086 | 2,091 | 2,026 | 2,039 | -97 | -4.5% | 231,100 |
2019/05/10 | 2,092 | 2,175 | 2,082 | 2,136 | +35 | +1.7% | 213,700 |
2019/05/09 | 2,137 | 2,166 | 2,082 | 2,101 | -66 | -3% | 322,400 |
2019/05/08 | 2,098 | 2,235 | 2,095 | 2,167 | +68 | +3.2% | 859,900 |
2019/05/07 | 2,009 | 2,201 | 2,009 | 2,099 | +99 | +5% | 738,200 |
2019/04/26 | 2,050 | 2,051 | 1,962 | 2,000 | -400 | -16.7% | 863,800 |
2019/04/25 | 2,418 | 2,430 | 2,393 | 2,400 | +4 | +0.2% | 223,000 |
2019/04/24 | 2,416 | 2,422 | 2,384 | 2,396 | -4 | -0.2% | 112,500 |
2019/04/23 | 2,400 | 2,406 | 2,379 | 2,400 | ±0 | ±0% | 84,700 |
2019/04/22 | 2,378 | 2,402 | 2,368 | 2,400 | +22 | +0.9% | 133,500 |
2019/04/19 | 2,394 | 2,409 | 2,366 | 2,378 | +1 | ±0% | 105,400 |
2019/04/18 | 2,420 | 2,422 | 2,364 | 2,377 | -33 | -1.4% | 209,300 |
2019/04/17 | 2,397 | 2,411 | 2,371 | 2,410 | +6 | +0.2% | 145,900 |
2019/04/16 | 2,412 | 2,414 | 2,385 | 2,404 | -31 | -1.3% | 134,300 |
2019/04/15 | 2,460 | 2,466 | 2,435 | 2,435 | +24 | +1% | 121,600 |
2019/04/12 | 2,453 | 2,462 | 2,403 | 2,411 | +8 | +0.3% | 114,900 |
2019/04/11 | 2,414 | 2,440 | 2,376 | 2,403 | +3 | +0.1% | 89,400 |
2019/04/10 | 2,388 | 2,423 | 2,366 | 2,400 | -15 | -0.6% | 105,100 |
2019/04/09 | 2,411 | 2,415 | 2,392 | 2,415 | -41 | -1.7% | 115,900 |
2019/04/08 | 2,440 | 2,461 | 2,430 | 2,456 | +16 | +0.7% | 181,500 |
2019/04/05 | 2,434 | 2,451 | 2,421 | 2,440 | -34 | -1.4% | 233,800 |
2019/04/04 | 2,464 | 2,492 | 2,446 | 2,474 | -19 | -0.8% | 119,400 |
2019/04/03 | 2,495 | 2,508 | 2,453 | 2,493 | -34 | -1.3% | 136,600 |
2019/04/02 | 2,639 | 2,660 | 2,515 | 2,527 | -86 | -3.3% | 105,900 |
2019/04/01 | 2,610 | 2,647 | 2,589 | 2,613 | +7 | +0.3% | 134,600 |
2019/03/29 | 2,545 | 2,620 | 2,541 | 2,606 | +82 | +3.2% | 141,500 |
2019/03/28 | 2,539 | 2,551 | 2,503 | 2,524 | -41 | -1.6% | 122,700 |
2019/03/27 | 2,611 | 2,625 | 2,557 | 2,565 | -87 | -3.3% | 147,300 |
2019/03/26 | 2,611 | 2,661 | 2,597 | 2,652 | +58 | +2.2% | 159,100 |
2019/03/25 | 2,614 | 2,617 | 2,568 | 2,594 | -47 | -1.8% | 151,200 |
2019/03/22 | 2,704 | 2,704 | 2,628 | 2,641 | -89 | -3.3% | 192,500 |
2019/03/20 | 2,732 | 2,743 | 2,705 | 2,730 | -8 | -0.3% | 78,000 |
2019/03/19 | 2,760 | 2,760 | 2,696 | 2,738 | -37 | -1.3% | 111,700 |
2019/03/18 | 2,820 | 2,835 | 2,763 | 2,775 | -20 | -0.7% | 108,900 |
2019/03/15 | 2,733 | 2,820 | 2,726 | 2,795 | +88 | +3.3% | 280,300 |
2019/03/14 | 2,725 | 2,749 | 2,646 | 2,707 | -46 | -1.7% | 286,300 |
2019/03/13 | 2,845 | 2,862 | 2,729 | 2,753 | -92 | -3.2% | 245,400 |
2019/03/12 | 2,800 | 2,849 | 2,793 | 2,845 | +52 | +1.9% | 171,100 |
2019/03/11 | 2,755 | 2,799 | 2,747 | 2,793 | +33 | +1.2% | 115,800 |
2019/03/08 | 2,746 | 2,786 | 2,740 | 2,760 | -39 | -1.4% | 158,200 |
2019/03/07 | 2,714 | 2,799 | 2,714 | 2,799 | +85 | +3.1% | 187,500 |
2019/03/06 | 2,725 | 2,725 | 2,690 | 2,714 | +1 | ±0% | 99,200 |
2019/03/05 | 2,657 | 2,717 | 2,650 | 2,713 | +33 | +1.2% | 99,500 |
2019/03/04 | 2,669 | 2,707 | 2,648 | 2,680 | +24 | +0.9% | 120,900 |
2019/03/01 | 2,620 | 2,677 | 2,612 | 2,656 | +44 | +1.7% | 115,300 |
1351~
1400
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム